Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Investigation

• Publication date

  1997-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI119498PMID 9185527PMCID PMC508155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development.

  1996cited by this paper
• Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

  1996cited by this paper
• Induction of T‐helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus

  1995cited by this paper
• Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e–minus hepatitis B virus mutants

  1995cited by this paper
• Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice.

  1995cited by this paper
• Hepatitis B virus immunopathogenesis.

  1995cited by this paper
• Hepatitis B virus transgenic mice: Insights into the virus and the disease

  1995cited by this paper
• Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

  1995influential reference
• Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte

  1994cited by this paper
• Distinguishing between acute and symptomatic chronic hepatitis B virus infection.

  1994cited by this paper
• Classification of chronic hepatitis: Diagnosis, grading and staging

  1994cited by this paper
• Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

  1994cited by this paper
• Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

  1994cited by this paper
• Interleukin 12 at the site of disease in tuberculosis.

  1994cited by this paper
• Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

  1994cited by this paper
• Quantitative assessment of serum IgM anti‐HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection

  1994cited by this paper
• Lymphocyte responses and cytokines.

  1994cited by this paper
• Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.

  1994cited by this paper
• Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

  1993cited by this paper
• Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism

  1993cited by this paper
• Serology of acute exacerbation in chronic hepatitis B virus infection.

  1993cited by this paper
• The serology of chronic hepatitis B infection revisited.

  1993cited by this paper
• Regulation of human cytolytic lymphocyte responses by interleukin-12.

  1992influential reference
• Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement

  1992cited by this paper
• Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice

  1992cited by this paper
• Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

  1992cited by this paper
• IL-12 augments antigen-dependent proliferation of activated T lymphocytes.

  1992cited by this paper
• Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B.

  1991cited by this paper
• Interferon production in patients infected with HIV-1.

  1989cited by this paper
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

  1989influential reference

• Activation of immune checkpoint OX40 inhibits HBV replication in a mouse model.

  2025cites this paper
• Interaction Analysis of Genetic Variation at Il12a and IL12B with Chronic Hepatitis B

  2025cites this paper
• Increased Levels of TNF-α, IL-6, and IL-10 are Associated with The Degree of Liver Fibrosis in Chronic Hepatitis B Patients with NUC Therapy

  2024cites this paper
• Cytokine and chemokine profiling in chronic hepatitis C and B virus infections with high viral load.

  2024cites this paper
• The Role of Interleukins in HBV Infection: A Narrative Review

  2023cites this paper
• Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk Factors

  2023cites this paper
• Correlation of IL-15 with viral load of hepatitis B and its role in the clearance of the virus

  2023cites this paper
• Non-immune functions of inflammatory cytokines targeted by anti-psoriatic biologics: a review

  2022cites this paper
• Cross-Species Transmission of Rabbit Hepatitis E Virus to Pigs and Evaluation of the Protection of a Virus-like Particle Vaccine against Rabbit Hepatitis E Virus Infection in Pigs

  2022cites this paper
• Immunization with Virus-Like Particle Vaccine Protects Rabbits against Hepatitis E-3 Virus Infection

  2022cites this paper
• Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses

  2022cites this paper
• Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines

  2022cites this paper
• Is Cure of Hepatitis B Infection a Mission Possible?

  2021cites this paper
• Strong association of functional polymorphism in IL‐12B with susceptibility to chronic hepatitis B in Tunisia

  2021cites this paper
• Review article: safety of new biologic agents for inflammatory bowel disease in the liver.

  2021cites this paper
• Cytokines and Chemokines Involved in Hepatitis B Surface Antigen Loss in Human Immunodeficiency Virus/Hepatitis B Virus Coinfected Patients

  2021cites this paper
• Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

  2021cites this paper
• Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs

  2021cites this paper
• Cytokines and Chemokines in HBV Infection

  2021cites this paper
• Serum Alanine Aminotransferase Flares In Chronic Hepatitis B: The Good and The Bad

  2020cites this paper
• Dynamics of Hepatitis B Virus Surface Antigen Level with Peripheral Blood Lymphocytes in Chronic Hepatitis B Infection

  2020cites this paper
• Single Nucleotide Polymorphisms in IFN-γ Signaling Pathway Associated with Risk of Hepatitis B Virus Infection in Chinese Children

  2020cites this paper
• Transcriptome analysis based on RNA-seq of common innate immune responses of flounder cells to IHNV, VHSV, and HIRRV

  2020cites this paper
• Carrot Pomace Polysaccharide (CPP) Improves Influenza Vaccine Efficacy in Immunosuppressed Mice via Dendritic Cell Activation

  2020cites this paper
• Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

  2020cites this paper
• Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis

  2020cites this paper
• Immunological Features of AECHB

  2019cites this paper
• Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

  2019cites this paper
• Evaluation of the protective effects of a nanogel-based vaccine against rabbit hepatitis E virus.

  2019cites this paper
• Acute Exacerbation of Chronic Hepatitis B: Volume 1. Definition, Research Technology, Virology, Genetics and Immunology

  2019cites this paper
• Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab

  2018cites this paper
• Cytokine and Chemokine Profiling in Patients with Hand, Foot and Mouth Disease in Singapore and Malaysia

  2018cites this paper
• Current concepts on immunopathogenesis of hepatitis B virus infection.

  2018cites this paper
• Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease

  2017cites this paper
• 88 – Infections Associated with Immunobiologics

  2017cites this paper
• Correlation between the HBsAg Level and the Peripheral Blood Lymphocytes Profile in Chronic Hepatitis B Patients from Malaysia

  2016cites this paper
• IL-7 Responses In Th17 Cells Are Dysregulated During HIV Infection

  2016cites this paper
• Lack of association between Interleukin-12 gene polymorphism (rs568408 G/A) and susceptibility to chronic hepatitis B virus infection

  2016cites this paper
• Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections

  2016cites this paper
• α-Mannosidase I Protein Expression in Peripheral Blood Mononuclear Cells Is Upregulated During Hepatitis B Virus Infection

  2016cites this paper
• Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

  2015cites this paper
• Up-regulation of IL-12 expression in patients with chronic hepatitis B is mediated by the PI3K/Akt pathway

  2015cites this paper
• Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.

  2015cites this paper
• The analysis of correlation between IL-12 gene expression and hepatitis B virus in the affected patients

  2015cites this paper
• Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting

  2015cites this paper
• Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation--an insight from human immunodeficiency virus/hepatitis B virus coinfection.

  2015cites this paper
• Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.

  2015cites this paper
• Role of IL-10-Producing Regulatory B Cells in Chronic Hepatitis B Virus Infection

  2015cites this paper
• CpG-ODNs induced changes in cytokine/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs

  2014cites this paper
• Psoriasis: Biologic treatment and liver disease

  2014cites this paper
• TCRγδ+CD4−CD8− T Cells Suppress the CD8+ T-Cell Response to Hepatitis B Virus Peptides, and Are Associated with Viral Control in Chronic Hepatitis B

  2014cites this paper
• Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination

  2014cites this paper
• IL-10 AND IFN-γ IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH ENTECAVIR–A CROSS-SECTIONAL PILOT STUDY

  2014cites this paper
• Effect of IL-12B, IL-2, TGF-β1, and IL-4 Polymorphism and Expression on Hepatitis B Progression

  2014cites this paper
• Serum carnitine level and its associated factors in patients with chronic viral hepatitis

  2014cites this paper
• Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.

  2014cites this paper
• Alteration of peripheral blood lymphocytes (PBLs) profile with HBsAg Level in patients with chronic Hepatitis B infection

  2014cites this paper
• Current information concerning association of IL-12 and hepatitis B infection.

  2014cites this paper
• Identification of Serum Cytokine Profiles Associated with HBeAg Seroconversion Following Antiviral Treatment Interruption

  2014cites this paper
• IgE anti Hepatitis B virus surface antigen antibodies detected in serum from inner city asthmatic and non asthmatic children.

  2014cites this paper
• (AID) Activation-induced Cytidine Deaminase Infection via a Cytidine Deaminase Trigger Restriction of Hepatitis B Virus ! Interleukin-1 and Tumor Necrosis Factor- Microbiology:

  2014cites this paper
• Frequency-dependent selection drives HBeAg seroconversion in chronic hepatitis B virus infection

  2013cites this paper
• Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection

  2013cites this paper
• Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

  2013cites this paper
• Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

  2013cites this paper
• Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)

  2013cites this paper
• Association study between polymorphism of interleukin 12B 1188A/C and hepatitis B virus infection in a Chinese Han population

  2013cites this paper
• The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C

  2013cites this paper
• Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

  2013cites this paper
• Serum IL-10 and IL-12p40 levels and IL28B Gene Polymorphisms: Pretreatment Prediction of Treatment Failure in Chronic Hepatitis C

  2013cites this paper
• Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

  2013cites this paper
• CD8low T-cell subpopulation is increased in patients with chronic hepatitis B virus infection.

  2013cites this paper
• Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase AID

  2013cites this paper
• Short Title. Initiation of HBeAg Seroconversion.

  2013cites this paper
• Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides

  2013cites this paper
• Role of Interferon-gamma and Interleukin-12 in the Immunopathogenesis of Hepatitis B Virus Infection

  2012cites this paper
• Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients

  2012cites this paper
• Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion: a need for more translational study.

  2012cites this paper
• Two cases of hepatitis B in patients with moderate to severe psoriasis with ustekinumab.

  2012cites this paper
• Immune Response and Viral Hepatitis B

  2012cites this paper
• Cytokine Levels and Histopathology in Chronic Hepatitis B and Chronic Hepatitis C

  2012cites this paper
• IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population

  2012cites this paper
• Relationships between tumour necrosis factor‐α, interleukin‐12B and interleukin‐10 gene polymorphisms and hepatitis B in Chinese Han haemodialysis patients

  2012cites this paper
• Single-Nucleotide Polymorphism at CYP27B1-1260, but Not VDR Taq I, Is Possibly Associated with Persistent Hepatitis B Virus Infection

  2012cites this paper
• Changes in Levels of Interleukin-8 in the Serum of Patients with Hepatitis B Virus Infection Correlate with HBe Seroconversion and Increased Levels of Interleukin-8 Indicate Resistance to IFN-alpha Therapy

  2012cites this paper
• A high serum interleukin‐12p40 level prior to Kasai surgery predict a favourable outcome in children with biliary atresia

  2012cites this paper
• Viral Adaptation to Host Immune Responses Occurs in Chronic Hepatitis B Virus (HBV) Infection, and Adaptation Is Greatest in HBV e Antigen-Negative Disease

  2011cites this paper
• Serological Study on HBV Infected Patients and Individuals Vaccinated with Recombinant HB Vaccine

  2011cites this paper
• Serum Interleukin (IL)-10 and IL-12 Levels and Il28B Gene Polymorphisms: Pretreatment Prediction of Treatment Failure in Chronic Hepatitis C

  2011cites this paper
• Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients.

  2011cites this paper
• Enhanced specific immune responses by CpG DNA in mice immunized with recombinant hepatitis B surface antigen and HB vaccine

  2011cites this paper
• CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase.

  2011cites this paper
• Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection

  2010cites this paper
• Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion.

  2010cites this paper
• The Host–pathogen Interaction during HBV Infection: Immunological Controversies

  2010cites this paper
• The host–virus relationship is often described by a series of organized virological and immunological events [1]: viral entry, propagation of the virus in the host and early activation of innate immunity followed by maturation

  2010cites this paper
• Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B

  2010cites this paper
• Do Liver IL-12 Levels Predict Sustained Response to IFN-α Therapy in Children with Chronic Hepatitis B?

  2010cites this paper
• Modulation of Serum Interleukin-18 Concentrations and Hepatitis B Virus DNA Levels During Interferon Therapy in Patients with Hepatitis B e-Antigen-Positive Chronic Hepatitis B

  2010cites this paper
• HBcAg induces interleukin‐10 production, inhibiting HBcAg‐specific Th17 responses in chronic hepatitis B patients

  2010cites this paper